Factors associated with loss to follow up in a primary healthcare clinic practicing test and treat Authors: Julius Kiwanuka1,2, Noah Kiwanuka3, Flavia.

Slides:



Advertisements
Similar presentations
HIV/AIDS in Ethiopia Daniel Yilma Jimma Univeristy, Ethiopia.
Advertisements

Loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi: Understanding outcomes and reasons Hannock Tweya, Salem Gugsa, Mina Hosseinipour,
Risk factors and true outcomes of children lost to follow-up from antiretroviral therapy in Lilongwe, Malawi C. Ardura Gracia, H. Tweya, C Feldacker, S.
PMTCT FAILURE: THE ROLE OF MATERNAL AND FACILITY –RELATED FACTORS ICASA Presentation 8 th to 12 th Dec 2013 Onono Maricianah 1, Elizabeth A. Bukusi 1,
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
Most deaths among children enrolled in two program settings in Cambodia occur within the first 6 months after enrolment. Early mortality rates were more.
Characteristics of clients undergoing repeat HIV counseling and testing compared to clients newly-tested for HIV in Nyanza Province Oyaro P, Owuor K, Ng’eno.
THE CORE STUDY COMPARING TWO STRATEGIES FOR ENROLLING HIV-INFECTED PREGNANT WOMEN FROM ANTENATAL CARE TO CARE AND TREATMENT SERVICES IN CAMEROON: CONTINUUM.
Primary Healthcare Facilities Deliver More Effective Antiretroviral Therapy: An Evaluation in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
Decentralization of HIV care and treatment services in Central Province, Kenya: Adult patient characteristics and outcomes Presenting author: William Reidy,
Operational challenge: Linkages from prevention of mother-to-child transmission services to care and treatment services in Zambia S. Okawa,
Preliminary findings of a routine PMTCT Option B+ programme in a rural district in Malawi Rebecca M. Coulborn 1, Laura Triviño Duran 1, Carol Metcalf 2,
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
Reproductive Health Needs of Men and Women Enrolled in HIV Care and Treatment Services Elaine Abrams August 12, 2008 Track 1.0 Meeting.
Attrition in HIV Care Attrition in HIV Care: Key Operational Challenge in implementing HIV Care and Treatment in Tanzania G R Somi _________ Ministry of.
Integrated Health Programs for Women and Children: Lessons from the Field Dr. Ambrose Misore Project Director, APHIA II Western, PATH’s Kenya Country Program.
Management and Development for Health (MDH)
Impact of HSV-2 suppressive therapy with daily acyclovir on HIV-1 disease progression: a randomized placebo- controlled trial in Rakai, Uganda Steven J.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
The Positive Predictive Value of World Health Organization (WHO) Immunologic Criteria for Treatment Failure in a Public Health Antiretroviral Delivery.
Factors Associated with Survival in HIV-Infected African Patients on Antiretroviral Therapy: The Impact of a Sampling-Based Approach to Address Losses.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Outcomes of newly diagnosed HIV- infected patients referred to care after Provider Initiated.
Good Three-year Outcomes of Antiretroviral Therapy at Multiple NGO- assisted facilities in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
Failure to Initiate ART, Loss to Follow-up and Mortality among HIV-infected Patients during the pre-ART period in Uganda Elvin H. Geng 1, Winnie Muyindike.
Risk of death among those awaiting treatment for HIV infection in Zimbabwe: adolescents are at particular risk ZIMA CONGRESS AUGUST 2015 VICTORIA.
Data dissemination meeting February 28, 2007 ICAP New York.
Outcomes of Antiretroviral Treatment Programs in Rural Lesotho: Health Centers and Hospitals Compared Niklaus Labhardt, Motlalepula Sello, Mamokone A.
Strategies for Management of Antiretroviral Therapy Study Wafaa El-Sadr and James Neaton for the SMART Study Team.
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
Attrition between TB / HIV testing and linkage to care in South Africa’s correctional facilities. 01 December 2015 Vincent Zishiri, Salome Charalambous,
BARRIERS TO AND FACILITATORS FOR RETENTION OF MOTHER BABY-PAIRS IN CARE IN ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV IN EASTERN UGANDA Gerald.
Successfully enrolled in HIV Care but not linked to timely Treatment: Poor retention and Monitoring of Pre-ART patients who are not yet eligible for ART.
Clinic systems should be adapted to maximize the benefits of point-of-care CD4 technology Point-of-Care CD4 Systems Integration in Uganda December 2011.
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
Improving health worldwide Implications for Monitoring of the HIV Care Cascade? Jim Todd MeSH Satellite Session IAS Durban, Monday 18 th.
Priscilla Tsondai, Lynne Wilkinson, Anna Grimsrud, Angelina Trivino,
Men are absent across the HIV continuum of care in a rural area of southern Mozambique Laura Fuente-Soro, Elisa Lopez-Varela, Orvalho Augusto , Charfudin.
Pregnancy and living with HIV
Earlier treatment and lower mortality in infants Initiating ART at
Gaps in the cascade of care in two high prevalence settings in Zimbabwe and Malawi Nolwenn Conan1, Cyrus Paye2, Erica Simons2, Abraham Mapfumo3, Tsitsi.
Acceptability of early HIV treatment among South Africa women N Garrett, E Norman, V Asari, N Naicker, N Majola, K Leask, Q Abdool Karim and SS Abdool.
Carolyn M. Audet. ; Erin Graves; Magdalena Bravo; Muktar H
BIPAI Network Experience with multi-month prescribing/refills (MMP)
Facility Community Linkages
Factors affecting virological failure in patients receiving antiretroviral therapy: a prospective HIV Clinical cohort in rural Uganda. Patrick Kazooba1,
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
First roll out of universal access to antiretroviral therapy under routine program conditions in rural Swaziland. Authors: Bernhard Kerschberger (1), Sikhathele.
Validating Definitions of Antiretroviral Treatment Failure in Malawi
Community ART delivery models for high patient’s retention and good
Predictors of antiretroviral treatment associated tuberculosis in Ethiopia: a nested case control study Nebiyu Mesfin, MD.
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
1University of Maryland; 2Futures Group International; 3CDC; 4USAID
What is AIDS? HIV is a virus that attacks the immune system. If untreated, a person’s immune system will eventually be completely destroyed. AIDS refers.
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
Juan Gonzalez Perez AIDS Healthcare Foundation
CommCare as a Tool to Reduce Loss to Follow Up
The role of CD4 in patient monitoring Amsterdam July 2018
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Community patient tracking by Lay Community Health Workers (CHWs) is an effective strategy towards the 2nd & 3rd 90 Morapedi Boitumelo M.
Tolerability of Isoniazid Preventive therapy Among HIV infected Cohort in Nigeria Folajinmi Oluwasina Strategic Information Unit AIDS Healthcare Foundation,
AIDS-related deaths the lowest this century
Management and Development for Health (MDH)
Multi-disease diagnostic integration
HIV Recency Testing in Rwanda
Factors associated with the high willingness to use Pre-exposure prophylaxis in female sex workers communities in Kampala, Uganda. Author: Dr. Bashir.
Treatment Outcome among patients on ART in Southern Tanzania: Does Time of ART initiation Matter?
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Public Health Implications
Presentation transcript:

Factors associated with loss to follow up in a primary healthcare clinic practicing test and treat Authors: Julius Kiwanuka1,2, Noah Kiwanuka3, Flavia Matovu Kiweewa3,4, Juan Gonzalez Perez5, Jonathan Kitonsa2,6 Authors’ Affiliation: AIDS Healthcare Foundation, Kampala, Uganda Makerere University School of Public Health, Kampala, Uganda. Makerere University School of Public Health, Epidemiology and Biostatistics, Kampala, Uganda. Makerere University John Hopkins Research Collaboration, Kampala, Uganda. AIDS Healthcare Foundation, Kigali, Rwanda. Medical Research Council Uganda Virus Research Institute, Masaka, Uganda

Background and rationale World health organisation (WHO) currently recommends T&T in all, regardless of CD4 cell count or WHO stage. Current HIV treatment programs especially in sub Saharan Africa are plagued with the challenge of patients‘ loss to follow up. To date, little information is available on factors associated with LTFU in a T&T setting. We set out to study factors associated with loss to follow up (LTFU) in a primary healthcare facility practicing T&T. UN 2015 report estimated that out of the 2.1m new infections recorded in 2013, almost half (48%) were in three SSA countries including Uganda. By 2013, an estimated 35 million people were living with HIV and only 13.6M estimated to be on treatment. Treatment demonstrates a protective effect against HIV infection in sero-discordant couples and currently WHO recommends wide spread ART coverage to reduce on community viral loads. Therefore, Its Up on this success of TasP, WHO thru UNAIDS has set ambitious testing and enrolment targets achievable by the year 2020. Putting the 90-90-90 campaign into perspective, HIV testing and immediate enrolment (Same Day Testing and Same Day Enrolment –SDT/SDE-) can be important in immediately increasing patients’ numbers into HIV programs. However, how long and well clients tested and enrolled instantly sieve HIV care as part of them, to ultimately stay in care, has not been widely studied. Experience from PMTCT programs where SDT/SDE has largely been practiced, indicate quite a large number (50%) of mothers (with their new-borne infants) getting lost shortly after delivery. Understanding time to patients’ attrition is important to mitigate it before it occurs whereas understanding the factors associated with it, provides insights into improvement of the overall HIV care cascade.

Methods We retrospectively sampled 600 patients from routine patients' data in OpenMRS at Masaka Regional Referral Hospital Uganda Cares clinic. Clinic started piloting T&T at the beginning of 2012. Included patients tested and initiated on ART from January 2012 to December 2014. Defined (T&T as Test date=ART start date; Deferred=Otherwise) Analysis date Dec-2014 We defined loss to follow up as; Failure of the client to show up at the Masaka clinic for at least 90 days from the date of their last scheduled appointment taking 31st December 2014 as the reference date. We determined cumulative incidence of loss to follow up at differing time intervals. Compared LTFU using competing risk regression Used multivariable cox proportional hazards regression model to determine factors associated with time to LTFU (with death as a competing risk).

Ethical Considerations Ethical review/approval was sought from the Makerere University School of Public Health Institutional Review Board (MUSPH-IRB). Engaged Clinic’s management where the study was conducted. Program data routinely collected and entered into an electronic records management system (OpenMRS) was extracted with patients’ identifying information only limited to a database Identification Number (patient ID). This was done to conserve the confidentiality of patients.

Results Baseline characteristics. Characteristic (s) Percent Started ART instantly 50% Females 64.7% Median Age (IQR) 30.4 (23.8-37.1) Median CD4 at Start of ART (IQR) 373 (204-570) Proportion of patients in WHO stage 3&4 15.2% Proportion of Patients with Access to Phone 43.5% Proportion with suspected or diagnosed TB 7.5%

Results.. Compared to the T&T group (12.3%,95% CI=7.9-17.5%), cumulative incidence of LTFU was 5.9% (95% CI=3.6- 9.0%) in the deferred group within 12 months of ART initiation Generated with Death as a competing risk Difference was sign (p=0.023).

Factors associated with LTFU

Sensitivity Analysis… Compared to the T&S group (13.3%,95% CI=8.8-18.8%), cumulative incidence of LTFU was 5.3% (95% CI=3.1- 8.3%) in the deferred group within 12 months of ART initiation Relaxed the conventional definition from starting Instantly to within 7 days Generated with Death as a competing risk Difference was sign (p=0.023).

Summary and conclusions Initiating on ART instantly (T&T) was associated with an elevated risk of LTFU. Advance disease (WHO stage 3 or 4) as well as TB suspicion were also associated with a higher risk of LTFU. Access to a mobile phone and high baseline CD4 (borderline sign) were protective against LTFU. Conclusion In a bid to achieve the 90-90-90 campaign, steep ART initiation should be backed by intensive pre-initiation and adherence counseling for better long term retention of patients.

Acknowledgement